Health Care Equipment & Services

Investor insight: Chairman Lekstrom Morgan Lee adds 34,000 shares to his 309k+ stake in Streamex Corp., signaling confidence amid GLDY token launch and market volatility.

HRT Financial’s rapid buy‑sell cycle of NewGenIvf shares signals a short‑term arbitrage strategy and may hint at a potential turnaround, giving investors a new angle on the distressed biotech’s valuation.

Cheng Yin Pan’s RSU exercise shows strong insider confidence in Prenetics Global’s growth—boosting investor sentiment and reinforcing long‑term value in genetic‑testing diagnostics.

CEO Bailey David F’s post‑reverse split buy of 90 M shares shows confidence in the company’s undervalued healthcare platform and may signal a rebound.

Agilon Health insider sales: COO Gertsch Timothy’s modest 8‑share sale on May 24 shows routine portfolio rebalancing, not a sign of trouble, while the company’s growth plans and strong share price gains stay positive.

Edwards Lifesciences insider trading: Bobo’s rapid buy‑sell patterns reveal a cautious yet bullish stance—watch for short‑term volatility around earnings and product launches.

Insider selling spikes at Hinge Health despite a strong rally—explore the sales pattern, market impact, and what it means for investors.

Veradigm’s insider buys and sells reveal a strategic shift to AI‑driven products and a relist plan, with executives buying shares while CFO stays neutral.

Shane Hilary’s new FONAR purchase signals confidence in the MRI platform’s growth and may boost long‑term investor interest in the company’s expanding tech portfolio.

Insider buying spurs optimism for Spectral AI after FDA clearance. Explore how John Di Maio’s recent share purchases could signal future upside.